Saturday, June 20, 2026

How Huons and Sanofi’s Vaccine Partnership Will Transform the Korean Market in 2026

Huons partners with Sanofi to distribute five vaccines in South Korea, enhancing access and leveraging cold chain logistics for better healthcare.

U.S. Strategy Shift: How North Korea Gains Strategic Leverage Amid Military Rivalry

U.S. strategy shifts may fuel an arms race, empowering North Korea's influence and complicating security dynamics in the region.

Deadpool and Wolverine Stars Hit a Home Run in Seoul!

Deadpool and Wolverine stars Ryan Reynolds and...

Tag: glucagon

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST's Meta via will present DA-1726, a dual-action obesity treatment, at the EASL Congress 2026, showcasing promising clinical trial results.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.